Conversely, the infection can attenuate key pro‐inflammatory mediators like TNF‐α, IFN‐γ, and IL‐12, thereby modulating the broader inflammatory network and potentially mitigating the escalation of intestinal inflammation characteristic of IBD. The gene discussed is TNF; the disease is inflammatory bowel disease.